Who invested in Crossbow Therapeutics?
One investor is on record as having backed Crossbow Therapeutics — Biotechnology company developing TCR-mimetic antibody immunotherapies for cancer, in Biotech. Each row below says whether the round came from the investor's own portfolio page or from the press.
Crossbow Therapeutics investors
The funds that backed Crossbow Therapeutics are in the directory.
If they wrote this cheque, they may write yours. Pitch2Fund scores your startup against every one of them, gives you the partner to write to, and drafts the email. Free.